CYP4X1 and malignant colon neoplasm: Here, it is elucidated that CYP4X1/sEH-dependent endocannabinoid metabolism governs immune evasion in colon cancer by promoting the infiltration of regulatory T cells (Tregs) and impairing CD8<sup>+</sup> T cell effector function.